During the opening ceremony of the BIO Asia-Taiwan Exhibition yesterday in Taipei, President Tsai Ing-wen (蔡英文) expressed the hope that advancements in Taiwan’s biotechnology industry would usher in major business opportunities from abroad, allowing the sector to reach NT$1 trillion (US$339.50 billion) in annual production.
Despite COVID-19, the annual biotech trade show attracted pharmaceutical and medical device companies from more than 500 nations, including the US, the UK, Australia, Switzerland and Malaysia.
The five-day exhibition is the first in-person international biotechnology trade show in Asia since the outbreak of COVID-19.
Photo: Chien Jung-fong, Taipei Times
Speaking at the opening ceremony, Tsai said that biotechnology is a crucial part of the “five plus two” innovative industries plan that she introduced during her first term, adding that she hopes the exhibition would be a platform for the nation to demonstrate innovativeness and accelerate the development of its biotech sector.
The nation would deregulate relevant laws to expedite the growth of the sector, she said.
The “five plus two” innovative industries plan refers to an initiative to develop an Asian equivalent of the US’ Silicon Valley, including biotech, green energy, industry 4.0, robotics, defense and aviation, as well as innovative agriculture and a circular economy.
Taiwan’s biomedical industry grew by 8.7 percent in annual revenue last year, a record high over the past few years, with the amount of capital invested reaching NT$55.1 billion, Tsai said, adding that digital medicine and precision medicine, two sectors that have shown great potential in recent years, are expected to grow significantly.
Cell therapy, regenerative medicine and genetic testing combined with big data analysis are also areas that have progressed a lot, while innovative medical devices, including nanomedical technology, are expected to receive more attention, she said.
New medicine development has also had breakthroughs, Tsai said, citing a licensing agreement signed in April by Taiwan’s Oneness Biotech Co Ltd and the Denmark-based Leo Pharma, a global leader in medical dermatology.
The agreement was signed to facilitate the development and introduction to the market of FB825, a drug candidate for novel atopic dermatitis and asthma, with an upfront payment to Oneness totaling US$530 million, the highest a Taiwanese company has ever received in such a deal.
Meanwhile, the National Biotechnology Research Park in collaboration with several multi-national pharmaceutical companies, accelerators and venture capital firms yesterday opened an accelerator hub for biomedical start-ups.
Speaking at the inauguration ceremony of the hub, former vice president Chen Chien-jen (陳建仁) said that the new facilities provide one-stop services to cultivate biomedical start-ups and has the potential to become the biggest accelerator hub in the field of biomedicine in the Asia-Pacific region.
The occupancy rate of biomedical companies at the park is 60 percent and the number is expected to reach 80 percent by the end of the year, Chen said, adding that growth at such a rate would be “beyond my imagination.”
Additional reporting by Chien Hui-ju
The Executive Yuan yesterday announced that registration for a one-time universal NT$10,000 cash handout to help people in Taiwan survive US tariffs and inflation would start on Nov. 5, with payouts available as early as Nov. 12. Who is eligible for the handout? Registered Taiwanese nationals are eligible, including those born in Taiwan before April 30 next year with a birth certificate. Non-registered nationals with residence permits, foreign permanent residents and foreign spouses of Taiwanese citizens with residence permits also qualify for the handouts. For people who meet the eligibility requirements, but passed away between yesterday and April 30 next year, surviving family members
The German city of Hamburg on Oct. 14 named a bridge “Kaohsiung-Brucke” after the Taiwanese city of Kaohsiung. The footbridge, formerly known as F566, is to the east of the Speicherstadt, the world’s largest warehouse district, and connects the Dar-es-Salaam-Platz to the Brooktorpromenade near the Port of Hamburg on the Elbe River. Timo Fischer, a Free Democratic Party member of the Hamburg-Mitte District Assembly, in May last year proposed the name change with support from members of the Social Democratic Party and the Christian Democratic Union. Kaohsiung and Hamburg in 1999 inked a sister city agreement, but despite more than a quarter-century of
Taiwanese officials are courting podcasters and influencers aligned with US President Donald Trump as they grow more worried the US leader could undermine Taiwanese interests in talks with China, people familiar with the matter said. Trump has said Taiwan would likely be on the agenda when he is expected to meet Chinese President Xi Jinping (習近平) next week in a bid to resolve persistent trade tensions. China has asked the White House to officially declare it “opposes” Taiwanese independence, Bloomberg reported last month, a concession that would mark a major diplomatic win for Beijing. President William Lai (賴清德) and his top officials
‘ONE CHINA’: A statement that Berlin decides its own China policy did not seem to sit well with Beijing, which offered only one meeting with the German official German Minister for Foreign Affairs Johann Wadephul’s trip to China has been canceled, a spokesperson for his ministry said yesterday, amid rising tensions between the two nations, including over Taiwan. Wadephul had planned to address Chinese curbs on rare earths during his visit, but his comments about Berlin deciding on the “design” of its “one China” policy ahead of the trip appear to have rankled China. Asked about Wadephul’s comments, Chinese Ministry of Foreign Affairs spokesman Guo Jiakun (郭嘉昆) said the “one China principle” has “no room for any self-definition.” In the interview published on Thursday, Wadephul said he would urge China to
RSS